RT Journal Article
T1 Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations.
A1 Lunardi, Mattia
A1 Louvard, Yves
A1 Lefevre, Thierry
A1 Stankovic, Goran
A1 Burzotta, Francesco
A1 Kassab, Ghassan S
A1 Lassen, Jens Flensted
A1 Darremont, Olivier
A1 Garg, Scot
A1 Koo, Bon-Kwon
A1 Holm, Niels Ramsing
A1 Johnson, Thomas W
A1 Pan, Manuel
A1 Chatzizisis, Yiannis S
A1 Banning, Adrian P
A1 Chieffo, Alaide
A1 Dudek, Dariusz
A1 Hildick-Smith, David
A1 Garot, Jerome
A1 Henry, Timothy D
A1 Dangas, George
A1 Stone, Gregg
A1 Krucoff, Mitchell W
A1 Cutlip, Donald
A1 Mehran, Roxana
A1 Wijns, William
A1 Sharif, Faisal
A1 Serruys, Patrick W
A1 Onuma, Yoshinobu
K1 Academic
K1 Research
K1 Consortium
K1 Bifurcation
K1 Clinical trials
K1 Endpoints
AB The Bifurcation Academic Research Consortium (Bif-ARC) project originated from the need to overcome the paucity of standardization and comparability between studies involving bifurcation coronary lesions. This document is the result of a collaborative effort between academic research organizations and the most renowned interventional cardiology societies focused on bifurcation lesions in Europe, the United States, and Asia. This consensus provides standardized definitions for bifurcation lesions; the criteria to judge the side branch relevance; the procedural, mechanistic, and clinical endpoints for every type of bifurcation study; and the follow-up methods. Considering the complexity of bifurcation lesions and their evaluation, detailed instructions and technical aspects for site and core laboratory analysis of bifurcation lesions are also reported. The recommendations included within this consensus will facilitate pooled analyses and the effective comparison of data in the future, improving the clinical relevance of trials in bifurcation lesions, and the quality of care in this subset of patients.
PB Europa Digital & Publishing
YR 2022
FD 2022-04-22
LK http://hdl.handle.net/10668/21632
UL http://hdl.handle.net/10668/21632
LA en
DS RISalud
RD Apr 7, 2025